HMG-COA REDUCTASE INHIBITORS (STATINS) ASSOCIATED TENDON RUPTURE: AN ANALYSIS OF REPORTS FROM THE FOOD AND DRUG ADMINISTRATION'S ADVERSE REPORTING SYSTEM

被引：0
|
作者：
Rafi, J. A. [1 ]
Arabyat, R. [1 ]
Chen, C. [1 ]
Raisch, D. W. [1 ]
机构：
[1] Univ New Mexico, Coll Pharm, Albuquerque, NM 87131 USA
来源：
VALUE IN HEALTH | 2016年 / 19卷 / 03期
关键词：
D O I：
10.1016/j.jval.2016.03.066
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCV1
引用
收藏
页码：A39 / A39
页数：1
相关论文
共 50 条
  • [21] SKELETAL ADVERSE EVENTS ASSOCIATED WITH IMMUNE CHECKPOINT INHIBITORS: EMERGING TRENDS FROM THE US FOOD AND DRUG ADMINISTRATION ADVERSE EVENT REPORTING SYSTEM
    Pundole, X.
    Sarangdhar, M.
    Suarez-Almazor, M. E.
    VALUE IN HEALTH, 2019, 22 : S486 - S486
  • [22] Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration's Adverse Event Reporting System
    Rogers, James R.
    Sarpatwari, Ameet
    Desai, Rishi J.
    Bohn, Justin M.
    Khan, Nazleen F.
    Kesselheim, Aaron S.
    Fischer, Michael A.
    Gagne, Joshua J.
    Connolly, John G.
    DRUG SAFETY, 2019, 42 (01) : 85 - 93
  • [23] Effect of Lawyer-Submitted Reports on Signals of Disproportional Reporting in the Food and Drug Administration’s Adverse Event Reporting System
    James R. Rogers
    Ameet Sarpatwari
    Rishi J. Desai
    Justin M. Bohn
    Nazleen F. Khan
    Aaron S. Kesselheim
    Michael A. Fischer
    Joshua J. Gagne
    John G. Connolly
    Drug Safety, 2019, 42 : 85 - 93
  • [24] Application of clinical pharmacology in pharmacoeconomics: Cost-effectiveness analysis of therapeutics using clinically equivalent doses: An example from HMG-COA reductase inhibitors (STATINS).
    Farahani, P.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 : S76 - S76
  • [25] Stroke, statins, and cholesterol - A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors
    Blauw, GJ
    Lagaay, AM
    Smelt, AHM
    Westendorp, RGJ
    STROKE, 1997, 28 (05) : 946 - 950
  • [26] A Summary of the Rare Reports of Osteonecrosis of the Jaw Associated With Tumor Necrosis-a Inhibitors in the United States Food and Drug Administration's Adverse Event Reporting System Database
    Wichelmann, Thomas Adam
    Ahdi, Hardeep S.
    Pandravada, Sasirekha
    Ehrenpreis, Eli D.
    JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 2023, 81 (10) : 1311 - 1318
  • [27] TREATMENT WITH HMG-CoA REDUCTASE INHIBITORS (STATINS) IS ASSOCIATED WITH PRESERVATION OF HEPATIC FUNCTION IN ADVANCED CHRONIC LIVER DISEASE (CLD): RESULTS FROM THE SHUNT-V STUDY
    Rahimi, Robert S.
    Annette, C.
    Simmons, Harold C.
    Lucas, Kathryn Jean
    Weinberg, Ethan M.
    Kayali, Zeid
    Bhagat, Vishal K.
    Keaveny, Andrew Paul
    Mantry, Parvez S.
    Smith, Alastair D.
    Kittelson, John M.
    Helmke, Steve M.
    Everson, Gregory T.
    HEPATOLOGY, 2021, 74 : 98A - 99A
  • [28] Atazanavir-associated nephrolithiasis: cases from the US food and drug administration's adverse event reporting system
    Chan-Tack, Kirk M.
    Truffa, Melissa M.
    Struble, Kimberly A.
    Birnkrant, Debra B.
    AIDS, 2007, 21 (09) : 1215 - 1218
  • [29] Statins (HMG-CoA reductase inhibitors) reduce CD40 expression in atheroma-associated cells. Possible implications for atherosclerosis and transplantation
    Mach, F
    Kwak, B
    Veillard, N
    Mulhaupt, F
    Pelli, G
    EUROPEAN HEART JOURNAL, 2001, 22 : 253 - 253
  • [30] Pediatric drug surveillance and the food and drug administration's adverse event reporting system: an overview of reports, 2003-2007
    Johann-Liang, Rosemary
    Wyeth, Jo
    Chen, Min
    Cope, Judith U.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (01) : 24 - 27
12345